Asociación Panamericana de Oftalmología PAAO, von-Bischho¬shausen FB, Castro FM, Terradella JV.
Actualización de la Guía clínica de Retinopatía Diabética para Latinoamérica. 2016.
Klein BE. Overview of epidemiologic studies of diabetic retinopathy.
Ophthalmic epidemiology. 2007;14(4):179-83.
Furtado JM, Lansingh VC, Carter MJ, Milanese MF, Pena BN, Ghersi HA, et al.
Causes of blindness and visual impairment in Latin America. Survey of ophthalmology. 2012;57(2):149-77.
Kempen JH, O’Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al.
The prevalence of diabetic retinopathy among adults in the United States. Archives of ophthalmology (Chicago, Ill : 1960). 2004;122(4):552-63.
Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al.
Prevalence of diabetic retinopathy in the United States, 2005-2008. Jama. 2010;304(6):649-56.
Marshall SM, Flyvbjerg A.
Prevention and early detection of vascular complications of diabetes. BMJ 2006;333:475-80.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al.; Meta-Analysis for Eye Disease (META-EYE) Study Group.
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-64.
Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A.
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev 2014;2:CD009122.